Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mo1350 - Parenchymal-Preserving Resection for Pancreatic Neuroendocrine Tumors: are the Outcomes Justified?

Autor: Miller, Braden N., Garnett, Gwendolyn, Morada, Anthony, Annamalai, Alagappan A., Hendifar, Andrew, Dhall, Deepti, Lo, Simon K., Wachsman, Ashley, Nissen, Nicholas N.

Publikováno v: In Gastroenterology April 2017 152(5) Supplement 1:S1274-S1274

A metabolic switch controls intestinal differentiation downstream of Adenomatous polyposis coli (APC).

Autor: Sandoval, Imelda T., Delacruz, Richard Glenn C., Miller, Braden N., Hill, Shauna, Olson, Kristofor A., Gabriel, Ana E., Boyd, Kevin, Satterfield, Christeena, Van Remmen, Holly, Rutter, Jared, Jones, David A.

Publikováno v: eLife; Apr2017, p1-18, 18p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas.

Autor: Delacruz RGC; Functional and Chemical Genomics, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Sandoval IT; Functional and Chemical Genomics, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Chang K; Department of Clinical Cancer Prevention, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA.; Graduate School of Biomedical Sciences, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Miller BN; Functional and Chemical Genomics, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.; College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Borras E; Department of Clinical Cancer Prevention, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Lynch PM; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA.; Clinical Genetics Program, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Taggart MW; Department of Pathology, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Hawk ET; Department of Clinical Cancer Prevention, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Vilar E; Department of Clinical Cancer Prevention, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA.; Department of GI Medical Oncology, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA.; Clinical Genetics Program, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA.; Graduate School of Biomedical Sciences, The University of Texas UTHealth MD Anderson Cancer Center, Houston, TX, USA., Jones DA; Functional and Chemical Genomics, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Publikováno v: Oncotarget [Oncotarget] 2019 Jun 11; Vol. 10 (39), pp. 3939-3951. Date of Electronic Publication: 2019 Jun 11 (Print Publication: 2019).